MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

An experimental obesity drug has shown it can “substantially” reduce weight within a year, offering new hope for people with ...

MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau, and Delivered Significant ...

A new experimental drug meant to be taken just once a month could lead to “substantial weight reduction” within a year and ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

Ania Jastreboff, MD, PhD, associate professor of internal medicine and pediatrics at Yale University School of Medicine, New Haven, Connecticut, spoke remotely about the current pharmacological ...

News 8 sat down with Dr. Ania Jastreboff, a Yale associate professor, endocrinologist and obesity medicine physician, to discuss these weight loss drugs. She leads the Yale Obesity Research Center ...

Oprah Winfrey is opening up about the impact of taking weight loss drugs on her perspective of “thin people.” During a conversation with Dr Ania Jastreboff on The Oprah Podcast, the 70-year ...